# Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical Trial

> **NCT07571837** · NA · RECRUITING · sponsor: **Al-Azhar University** · enrollment: 63 (estimated)

## Conditions studied

- Post-operative Pain
- Periapical Inflammation

## Interventions

- **DRUG:** Nanochitosan paste
- **DRUG:** Nano-calcium hydroxide paste
- **DRUG:** Calcium hydroxide paste

## Key facts

- **NCT ID:** NCT07571837
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-01-30
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07571837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07571837, "Modulation of Periapical Inflammation Following Nano-sized Intracanal Medication. A Randomized Controlled Clinical Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07571837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*